D. Stephen Charnock-Jones

Professor of Reproductive Biology

University of Cambridge
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

D. Stephen Charnock-Jones is a Professor of Reproductive Biology at the University of Cambridge, UK. His research primarily focuses on the human placenta and its implications for reproductive outcomes, including adverse pregnancy outcomes and predictive modeling using metabolomic data. Recent articles highlight his contributions to understanding gestational diabetes mellitus, preterm birth prediction, and placental biomarkers in early pregnancy.

Articles (13)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Objectives To identify and internally validate metabolites predictive of spontaneous preterm birth (sPTB) using multiple machine learning methods and sequential maternal serum samples, and to predict spontaneous early term birth (sETB) using these metabolites. Design Case–cohort design within a prospective cohort study. Setting Cambridge, UK. Population or sample A total of 399 Pregnancy Outcome Prediction study participants, including 98 cases of sPTB. Methods An untargeted metabolomic analysis of maternal serum samples at 12, 20, 28 and 36 weeks of gestation was performed. We applied six supervised machine learning methods and a weighted Cox model to measurements at 28 weeks of gestation and sPTB, followed by feature selection. We used logistic regression with elastic net penalty, followed by best subset selection, to reduce the number of predictive metabolites further. We applied coefficients from the chosen models to measurements from different gestational ages to predict sPTB and sETB. Main outcome measures sPTB and sETB. Results We identified 47 metabolites, mostly lipids, as important predictors of sPTB by two or more methods and 22 were identified by three or more methods. The best 4‐predictor model had an optimism‐corrected area under the receiver operating characteristics curve (AUC) of 0.703 at 28 weeks of gestation. The model also predicted sPTB in 12‐week samples (0.606, 95% CI 0.544–0.667) and 20‐week samples (0.657, 95% CI 0.597–0.717) and it predicted sETB in 36‐week samples (0.727, 95% CI 0.606–0.849). A lysolipid, 1‐palmitoleoyl‐GPE (16:1)*, was the strongest predictor of sPTB at 12 weeks of gestation (0.609, 95% CI 0.548–0.670), 20 weeks (0.630, 95% CI 0.569–0.690) and 28 weeks (0.660, 95% CI 0.599–0.722), and of sETB at 36 weeks (0.739, 95% CI 0.618–0.860). Conclusions We identified and internally validated maternal serum metabolites predictive of sPTB. A lysolipid, 1‐palmitoleoyl‐GPE (16:1)*, is a novel predictor of sPTB and sETB. Further validation in external populations is required.

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Andrew Murray

Reader in Metabolic Physiology

University of Cambridge

UNITED KINGDOM
View details

Neil Sebire

University College London

UNITED KINGDOM
View details

Gemma Clayton

University of Bristol

UNITED KINGDOM
View details

Neil Goulding

University of Bristol

UNITED KINGDOM
View details

Paul Robson

Professor

Jackson Laboratory - Farmington

UNITED STATES
View details

Irving L. M. H. Aye

University of Cambridge

UNITED KINGDOM
View details

Nancy McBride

University of Bristol

UNITED KINGDOM
View details

Stephen Tong

Professor

University of Melbourne

AUSTRALIA
View details

Ulla Sovio

-

UNITED KINGDOM
View details

Gordon Smith

Professor & Head of Department

University of Cambridge

UNITED KINGDOM
View details

Saverio Tardito

University of Glasgow

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.